Literature DB >> 18223677

Post-translational regulation of the ERK phosphatase DUSP6/MKP3 by the mTOR pathway.

O Bermudez1, S Marchetti, G Pagès, C Gimond.   

Abstract

MAP kinases phosphatases (MKPs) belong to the dual-specificity phosphatase family (DUSP) and dephosphorylate phosphothreonine and phosphotyrosine within MAP kinases. We had previously shown that DUSP6/MKP-3 was phosphorylated and degraded upon growth factor stimulation, in a MEK-dependent manner. Here we show that another pathway involved in growth factor signaling, the PI3K/mTOR signaling pathway, accounts for a part of the phosphorylation and degradation of DUSP6 induced by serum growth factors, as evidenced by experiments using pharmacological inhibitors of PI3 kinase and mammalian target of rapamycin (mTOR). Moreover, specific agonists of the mTOR pathway, such as amino acids or insulin/IGF-1, which do not activate extracellular signal regulated kinases (ERKs) in our cellular model, were also able to induce the phosphorylation and degradation of DUSP6. However, a basal activity of MEK was required for the mTOR pathway-mediated phosphorylation to occur. Mutagenesis studies identified serine 159 within DUSP6 as the target of the mTOR pathway. The ERK phosphatase DUSP6 may thus constitute a novel branch-point of the crosstalk between two major signaling pathways induced by growth factors, the MEK/ERK pathway and the PI3K/mTOR pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18223677     DOI: 10.1038/sj.onc.1211040

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  Mechanisms of regulation of oligodendrocyte development by p38 mitogen-activated protein kinase.

Authors:  Li-Jin Chew; William Coley; Ying Cheng; Vittorio Gallo
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

2.  Prognostic value of dual-specificity phosphatase 6 expression in non-small cell lung cancer.

Authors:  C Vanesa Díaz-García; Alba Agudo-López; Carlos Pérez; Elena Prieto-García; Lara Iglesias; Santiago Ponce; Analia Rodríguez Garzotto; José L Rodríguez-Peralto; Hernán Cortés-Funes; José A López-Martín; M Teresa Agulló-Ortuño
Journal:  Tumour Biol       Date:  2014-10-25

3.  Dysregulation of p38 and MKP-1 in response to NOD1/TLR4 stimulation in sarcoid bronchoalveolar cells.

Authors:  Ruchi Rastogi; Wenjin Du; Donhong Ju; Gaila Pirockinaite; Yusen Liu; Gabriel Nunez; Lobelia Samavati
Journal:  Am J Respir Crit Care Med       Date:  2010-09-17       Impact factor: 21.405

4.  MEK/ERK pathway mediates insulin-promoted degradation of MKP-3 protein in liver cells.

Authors:  Bin Feng; Ping Jiao; Zaiqing Yang; Haiyan Xu
Journal:  Mol Cell Endocrinol       Date:  2012-04-12       Impact factor: 4.102

5.  Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis.

Authors:  Koji Okudela; Takuya Yazawa; Tetsukan Woo; Masashi Sakaeda; Jun Ishii; Hideaki Mitsui; Hiroaki Shimoyamada; Hanako Sato; Michihiko Tajiri; Nobuo Ogawa; Munetaka Masuda; Takashi Takahashi; Haruhiko Sugimura; Hitoshi Kitamura
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

6.  Role of ERK/mTOR signaling in TGFbeta-modulated focal adhesion kinase mRNA stability and protein synthesis in cultured rat IEC-6 intestinal epithelial cells.

Authors:  Silke Suer; Dinakar Ampasala; Mary F Walsh; Marc D Basson
Journal:  Cell Tissue Res       Date:  2009-04-02       Impact factor: 5.249

7.  Rapid actions of xenoestrogens disrupt normal estrogenic signaling.

Authors:  Cheryl S Watson; Guangzhen Hu; Adriana A Paulucci-Holthauzen
Journal:  Steroids       Date:  2013-11-20       Impact factor: 2.668

8.  Follicle-Stimulating Hormone (FSH)-dependent Regulation of Extracellular Regulated Kinase (ERK) Phosphorylation by the Mitogen-activated Protein (MAP) Kinase Phosphatase MKP3.

Authors:  Elyse M Donaubauer; Nathan C Law; Mary E Hunzicker-Dunn
Journal:  J Biol Chem       Date:  2016-07-15       Impact factor: 5.157

9.  FOXO1-dependent up-regulation of MAP kinase phosphatase 3 (MKP-3) mediates glucocorticoid-induced hepatic lipid accumulation in mice.

Authors:  Bin Feng; Qin He; Haiyan Xu
Journal:  Mol Cell Endocrinol       Date:  2014-06-16       Impact factor: 4.102

Review 10.  Targeting the mTOR signaling network for cancer therapy.

Authors:  Funda Meric-Bernstam; Ana Maria Gonzalez-Angulo
Journal:  J Clin Oncol       Date:  2009-03-30       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.